ANXA2 promotes the invasion and metastasis of different cancers (ovarian cancer, HCC, gliomas, pancreatic cancer, renal cell carcinoma, lung cancer, breast cancer, and NPC) [8–12, 42–44]. Here, ANXA2 is linked to hepatocellular carcinoma.